POR CVM-1118 (foslinanib), a 2-phenyl-4-quinolone derivative
Por um escritor misterioso
Last updated 27 março 2025

CVM-1118 (foslinanib) is a phosphoric ester compound selected from 2-phenyl-4-quinolone derivatives. The NCI 60 cancer panel screening showed CVM-1125, the major active metabolite of CVM-1118, to exhibit growth inhibitory and cytotoxic effects at nanomolar range. CVM-1118 possesses multiple bioactivities, including inducing cellular apoptosis, cell cycle arrest at G2/M, as well as inhibiting vasculogenic mimicry (VM) formation. The TNF receptor associated protein 1 (TRAP1) was identified as the binding target of CVM-1125 using nematic protein organization technique (NPOT) interactome analysis. Further studies demonstrated CVM-1125 reduced the protein level of TRAP1 and impeded its downstream signaling by reduction of cellular succinate levels and destabilization of HIF-1α. The pharmacogenomic biomarkers associated with CVM-1118 were also examined by Whole Genome CRISPR Knock-Out Screening. Two hits (STK11 and NF2) were confirmed with higher sensitivity to the drug in cell knock-down experiments. Biological assays indicate that the mechanism of action of CVM-1118 is via targeting TRAP1 to induce mitochondrial apoptosis, suppress tumor cell growth, and inhibit vasculogenic mimicry formation. Most importantly, the loss-of-function mutations of STK11 and NF2 are potential biomarkers of CVM-1118 which can be applied in the selection of cancer patients for CVM-1118 treatment. CVM-1118 is currently in its Phase 2a clinical development.

Full article: Developing our knowledge of the quinolone scaffold and its value to anticancer drug design

HSP 75 Antibody (TR1) SCBT - Santa Cruz Biotechnology

LKB1-deficient tumor cells display enhanced glycolytic and TCA cycle

POR Three-dimensional analysis of perineural invasion in extrahepatic cholangiocarcinoma using tissue clearing

A complex-level interaction network. a, a fragment of our Complex- Net

Effect of evodiamine on ABCA1 transcription and the degradation rate of

TRAP1 Knockdown Inhibits In Vitro and In Vivo Neoplastic Transformation

POR CVM-1118 (foslinanib), a 2-phenyl-4-quinolone derivative, promotes apoptosis and inhibits vasculogenic mimicry via targeting TRAP1

Molecules, Free Full-Text
Foslinanib, C16H13FNO6P

Molecules, Free Full-Text

HIF-1α Antibody Cell Signaling Technology
Recomendado para você
-
Chinese Wall: o mecanismo que protege informações privilegiadas27 março 2025
-
O que é Chinese Wall ?, CPA20 - ANCORD27 março 2025
-
Michigan State University College of Veterinary Medicine Employees27 março 2025
-
FDA CVM Drug Promotion – Truth about Pet Food27 março 2025
-
Conflitos de interesse: Aspectos societários após a Resolução 17827 março 2025
-
Vintage Portuguese Shrine Senhor Santo Cristo Abencoai Nosso27 março 2025
-
3D chromatographic fingerprint analysis of the CVM B307 by using27 março 2025
-
CVM ENTERPRISES - 86 Photos & 10 Reviews - St. Louis, Missouri27 março 2025
-
CVM London27 março 2025
-
Victoria Vigstrom - University of Arizona - Tucson, Arizona27 março 2025
você pode gostar
-
Playstation Xbox Xbox 360 Pcdvd and other Games27 março 2025
-
Gun Box 3, Murder Mystery 2 Wiki27 março 2025
-
PRE-ORDER - Gears of War Dominic Santiago 1/12 Scale Figure – TOYCO Collectibles27 março 2025
-
Liverpool não pode depender de Salah, Mané e Firmino para sempre27 março 2025
-
Someone is excited about the FNAF movie! : r/MASFandom27 março 2025
-
Kamisama ni Natta Hi T.V. Media Review Episode 127 março 2025
-
Play Microsoft Solitaire 🕹️ Game for Free at !27 março 2025
-
manualidades con rollos de carton - Craftingeek27 março 2025
-
English-Catalan Learner's Dictionary (Arranged by Themes, Beginner27 março 2025
-
Parappa The Rapper - Parappa The Rapper - Posters and Art Prints27 março 2025